Press release
Neuropsychiatric Disorders and Treatment Market: Worldwide Top Key Players - Biogen (US), Boehringer Ingelheim GmbH (Germany), Eli Lilly (US), Bristol-Meyer Squibb (US), Johnson & Johnson (US), Pfizer (US), Wyeth
Market Research Future published a Half-Cooked Research Report on “Global Neuropsychiatric Disorders and Treatment Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.Neuropsychiatric disorders are mental disorder occur due to disturbance in the function of cerebral system. Neuropsychiatric disorders are most common to the people having more than 65 year’s age. Increasing prevalence of neuropsychiatric disorders across the globe is the major reason for driving the market. Beside this increasing demand for the better treatment and development in the healthcare sector are the major driving factor for the growth of the market. While lack of clinical trial data for neuropsychiatric drugs and long term treatment of this diseases may restrain the growth of the market.
Geographically, North America accounts for the largest market for the neuropsychiatric disorders and treatment which is slightly less than Europe. Huge population suffering from neuropsychiatric disorders in this region is the major reason for the development of the market. According to WHO the number of patients suffering from neuropsychiatric disorders will be doubled in next couple of decades due to increasing aging population in North America and Europe. Asia Pacific has the third leading market which is expecting a fastest growth in this market due to rapid development in healthcare sector and increasing demand for the better treatment of the neuropsychiatric disorders.
Get a sample report at https://www.marketresearchfuture.com/sample_request/1281 .
AstraZeneca (UK), GlaxoSmithKline (UK), Universal Health Services Inc. (US), Biogen (US), Boehringer Ingelheim GmbH (Germany), Eli Lilly (US), Bristol-Meyer Squibb (US), Johnson & Johnson (US), Pfizer (US), Wyeth (US), Otsuka Holdings Co. Ltd (Japan), Astellas Pharma Inc. (Japan) are some of the prominent players at the forefront of competition in the Global neuropsychiatric disorders and treatment Market and are profiled in MRFR Analysis.
Global Neuropsychiatric Disorders and Treatment Market - Competitive Analysis
Many factors are fuelling the growth of the market. This has attracted many of the manufacturer for development of the market in this sector. Increasing in alliances amongst the leading player has helped to introduction of new and better treatment for the neuropsychiatric disorders.
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company headquartered in UK. Recently AstraZeneca has completed its collaboration with National Institute of Mental Health. This collaboration will help to discover the new and better drug treatment for distressing condition. AstraZeneca has also collaborated with Vanderbilt Center for the Neuroscience Drug Discovery which aims to discover new drug for the treatment of neuropsychiatric disorders.
Universal Health Services is an American Fortune 500 company headquartered in US. It is one of the largest hospital management companies in US. Universal Health Services is a huge company with the revenues of nearly USD 9.7 billion with the profit of more than USD 600 million.
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies headquartered in Germany. In 2016, Boehringer Ingelheim is collaborated with Saniona. This collaboration aims to develop the new treatment for the patients suffering from schizophrenia.
Browse Complete Report at https://www.marketresearchfuture.com/reports/neuropsychiatric-disorders-treatment-market-1281 .
Global Neuropsychiatric Disorders and Treatment Market- Regional Analysis
On regional basis, global neuropsychiatric disorders and treatment market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America commands the largest market for the neuropsychiatric disorders and treatment. In North America neuropsychiatric disorders account the highest rate of disability-adjusted life year (DALYs). DALYs is a measure of overall disease burden which express the number of years lost due to ill health or early death. According to Centers for Disease Control and Prevention, around 5.3 million Americas are suffering from this diseases and this number is expected get double in next couple of decades due to due to the aging of the population. This increasing number of the neuropsychiatric patients in North America has led to the growth of this market in North America.
Europe commands the second largest market for the neuropsychiatric disorders and treatment. Huge population suffering from mental disorders in Iceland, Norway and Switzerland has contributed a lot for the European market. Moreover, increasing demand for need of better treatment and increasing burden of neuropsychiatric disorders are the major factor for the growth of the market.
Neuropsychiatric disorders and treatment market in Asia Pacific is growing at a steady pace due to huge geriatric population in this area, continuous improving healthcare infrastructure and rapid development in healthcare sector has boosted growth of this market. The Middle East and Africa has least market for the neuropsychiatric disorders and treatment.
About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
P: +1 646 845 9312
W: www.marketresearchfuture.com
sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropsychiatric Disorders and Treatment Market: Worldwide Top Key Players - Biogen (US), Boehringer Ingelheim GmbH (Germany), Eli Lilly (US), Bristol-Meyer Squibb (US), Johnson & Johnson (US), Pfizer (US), Wyeth here
News-ID: 949416 • Views: …
More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035.
Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial…

Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035.
Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are…

Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034.
Cheese packaging…

Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by…
More Releases for Neuropsychiatric
Neuropsychiatric Disorders and Treatment Market Set to Dominate with $383.13 Bil …
The Neuropsychiatric Disorders and Treatment Market is gaining significant traction worldwide as awareness of mental health continues to grow and demand for effective therapies accelerates. Conditions such as depression, anxiety, schizophrenia, bipolar disorder, and Alzheimer's disease affect millions of individuals, creating a growing need for specialized treatments and holistic care approaches. Pharmaceutical innovation, government initiatives, and digital health solutions are driving the industry forward, making neuropsychiatric care a critical component…
Neuropsychiatric Drugs Market Forecast Highlights Growth Opportunities Fueled by …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Neuropsychiatric Drugs Market- By Trends, Industry Competition Analysis, Revenue and Forecast to 2034."
The Neuropsychiatric Drugs Market is expected to grow at a 5.0 % CAGR during the forecast period for 2025-2034.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1170
Neuropsychiatric disorders represent a broad category of medical conditions that intersect the disciplines of neurology…
Neuropsychiatric Drug Market Revenue Growth and Challenges Impacting Adoption Ra …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Neuropsychiatric Drugs Market- By Trends, Industry Competition Analysis, Revenue and Forecast to 2031."
The Neuropsychiatric Drugs Market is expected to grow at a 4.5 % CAGR during the forecast period for 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1170
Neuropsychiatric disorders encompass a wide spectrum of medical conditions that bridge the fields of neurology…
Neuropsychiatric Disorders Treatment Market - A Comprehensive Study by Key Playe …
Pro Market Reports published a new research publication on "Neuropsychiatric Disorders Treatment Market" with 230+ pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Neuropsychiatric Disorders Treatment market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in…
Global Neuropsychiatric Drugs Market Size, Share, Growth and Trends Study Report …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Neuropsychiatric Drugs Market- By Trends, Industry Competition Analysis, Revenue and Forecast to 2030."
Request for Sample Pages:
Neuropsychiatric disorders include a broad range of medical conditions that consist of both neurology and psychiatry. Disturbance in the function of the cerebral system leads to mental disorders. These disorders are majorly observed in children and adolescents. Numerous drugs are available…
Global Neuropsychiatric Drugs Market– By Trends, Industry Competition Analysis …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on "Global Neuropsychiatric Drugs Market– By Trends, Industry Competition Analysis, Revenue and Forecast to 2030."
Request for Sample Pages: https://www.insightaceanalytic.com/report/global-neuropsychiatric-drugs-market-/1170
Neuropsychiatric disorders include a broad range of medical conditions that consist of both neurology and psychiatry. Disturbance in the function of the cerebral system leads to mental disorders. These disorders are majorly observed in children and adolescents. Numerous drugs are…